We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Novel Insights in the Metabolic Syndrome in Childhood and Adolescence.
- Authors
Bussler, Sarah; Penke, Melanie; Flemming, Gunter; Elhassan, Yasir S.; Kratzsch, Jürgen; Sergeyev, Elena; Lipek, Tobias; Vogel, Mandy; Spielau, Ulrike; Körner, Antje; de Giorgis, Tommaso; Kiess, Wieland
- Abstract
Metabolic syndrome (MetS) is recognized as an escalating major health risk in adults as well as in children and adolescents. Its prevalence ranges from 6 to 39% depending on the applied definition criteria. To date, there is no consensus on a MetS definition for children and adolescents. However, most authors agree on essential components such as glucose intolerance, central obesity, hypertension and dyslipidemia; each representing a risk for cardiovascular disease. Recently, associations between MetS and non-alcoholic fatty liver disease, hyperuricemia and sleep disturbances have emerged. Biomarkers like adipocytokines are a subject of current research as they are implicated in the pathogenesis of the MetS. Epigenetics and gestational programming, especially the role of microRNA, comprise a novel, rapidly developing and promising research focus on the topic of MetS. MicroRNAs are increasingly valued for potential roles in the diagnosis, stratification and therapeutics of MetS. Early detection of risk factors, screening for metabolic disturbances, and the identification of new therapies are major aims to reduce morbidity and mortality related to MetS. Dietary modification and physical activity are currently the only adopted treatment approaches. Pharmacological therapies and bariatric surgery are still contradictory and therefore, are only recommended in selected high-risk cases.
- Subjects
METABOLIC syndrome; DISEASES in teenagers; JUVENILE diseases
- Publication
Hormone Research in Paediatrics, 2017, Vol 88, Issue 3/4, p181
- ISSN
1663-2818
- Publication type
Article
- DOI
10.1159/000479510